Opko Health, Inc. – ‘RW’ on 11/27/02

On:  Wednesday, 11/27/02, at 2:04pm ET   ·   Accession #:  950134-2-15075   ·   File #:  333-100906

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Registration Withdrawal Request
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: RW          Request for Withdrawal of Registration Statement       1      6K 

RW
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
 [EXEGENICS INC. LETTERHEAD]

                                                             November 27, 2002

VIA EDGAR                                                                       

Securities and Exchange Commission                                              
450 Fifth Street, N.W.                                                          
Washington, D.C. 20549                                                          

Re:   eXegenics Inc.                                          
 Registration Statement on Form S-4 (No. 333-100906)

Ladies and Gentlemen:                                                           

       Pursuant to Rule 477 promulgated under the Securities Act of 1933, as
amended, eXegenics Inc. (the "Company") hereby requests that the Securities and 
Exchange Commission approve the withdrawal of the above-referenced registration 
statement, which was originally filed with the Securities and Exchange          
Commission on October 31, 2002.                                                 

      The registration statement was filed in connection with the proposed
merger of a subsidiary of the Company with Innovative Drug Delivery Systems,    
Inc. The Company requests withdrawal of the registration statement due to the   
termination of the merger agreement by the parties on November 25, 2002. No     
securities have been sold under the registration statement.                     

      Please contact our counsel, Joel I. Papernik, of Mintz, Levin, Cohn,
Ferris, Glovsky and Popeo, P.C., at (212) 935-3000 with any questions concerning
this application.                                                               

              Sincerely,

                              /s/ Ronald L. Goode, Ph.D.
                                         -------------------------------------
                          Ronald L. Goode, Ph.D.
                                         President and Chief Executive Officer

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘RW’ Filing		Date		Other Filings
Filed on:		11/27/02
		11/25/02		8-K
		10/31/02		S-4
				List all Filings